|
Archive News
2009 |2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
To download and view any of the documents listed below, click on the links. To view or print the Portable Document Format (PDF) files, you will need Adobe Acrobat Viewer installed on your system.
If you do not have the latest Adobe Viewer, please download it here before you attempt to open the desired file.
Please click here to listen to archived boardroom radio presentations
| 2008 |
|
|
|
| December 24, 2008 |
 |
2009 shareholder notice of meeting for Arana
Therapeutics Limited |
|
| December 15, 2008 |
|
AAH - CEO Profile - Dr Steffen Nock, Acting CEO |
|
| December 11, 2008 |
|
AAH - Arana Commences International Phase II Rheumatoid Arthritis Trial - Dr David Fuller, Chief Medical Officer |
|
| December 11, 2008 |
|
Arana commences international Phase II trial in RA |
|
| November 27, 2008 |
|
Arana Therapeutics Completes Second Project for GSK |
|
| November 26, 2008 |
|
Arana commences ART621 Phase II rheumatoid arthritis trial |
|
| November 26, 2008 |
|
Arana News - November 2008
|
|
| November 19, 2008 |
|
|
|
| November 19, 2008 |
|
|
|
| November 19, 2008 |
|
Innovation Minister Gavin Jennings- Media Release- ANOTHER BOOST TO VICTORIAN BIOTECH INVESTMENT AND JOBS |
TOP |
| November 13, 2008 |
|
AAH - Full Year Results 2008 - Mr Robin Beaumont, Chairman and Mr Niall Henderson, CFO |
|
| November 12, 2008 |
|
Arana Full Year results media release |
|
| November 12, 2008 |
|
Arana Full Year Results |
|
| November 12, 2008 |
|
Arana Announces Appointment of Acting CEO |
|
| November 6, 2008 |
|
Arana Announces Resignation of CEO |
|
| November 4, 2008 |
|
AAH - FDA Accepts Arana's Anti-Inflammatory IND - Dr David Fuller, Chief Medical Officer |
|
| November 3, 2008 |
|
FDA accepts Arana`s anti-inflammatory IND |
|
| October 8, 2008 |
|
Arana Strengthens Board with New Appointment |
|
| October 8, 2008 |
|
Arana Announces On-Market Share Buy-back |
|
| October 2, 2008 |
|
Arana Completes a Series of Antibodies for Vegenics |
|
| September 30, 2008 |
|
Arana Files IND for Lead Anti-Inflammatory Product ART621 |
|
| September 22, 2008 |
|
Arana Updates Inflammatory Pipeline Milestones |
|
| August 28, 2008 |
|
AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer |
|
| August 28, 2008 |
|
Arana Announces Key Anti-Inflammatory Drug Milestone |
TOP |
| August 13, 2008 |
|
Results of meeting |
|
| August 7, 2008 |
|
AAH - Corporate Overview - Dr John Chiplin, CEO, Boardroom Radio interview |
|
| July 28, 2008 |
|
Arana Therapeutics expands clinical research team |
|
| July 14, 2008 |
|
Shareholder general meeting |
|
| July 3, 2008 |
|
|
|
| July 3, 2008 |
|
|
|
| July 3, 2008 |
|
SENATOR KIM CARR - MEDIA RELEASE AND SPEECH - NEW R&D FACILITY LEADS WAY FOR AUSTRALIAN BIOTECH SECTOR - 3 JULY 2008 |
|
| June 25, 2008 |
|
Arana Half Year Report – March 2008 |
|
| June 24, 2008 |
|
AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc, Boardroom Radio interview |
|
| June 5, 2008 |
|
Arana Therapeutics completes second project with CSL |
|
| June 3, 2008 |
|
Arana and Greenovation enter into a collaboration agreement |
|
| May 23, 2008 |
|
Arana 2008 Half Year Report, Boardroom Radio interview |
|
| May 21, 2008 |
|
Arana 2008 Half Year Report |
|
| April 28, 2008 |
|
AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug, Boardroom Radio interview |
TOP |
| April 28, 2008 |
|
Excellence in Biotechnology Investment Presentation, Boardroom Radio interview |
|
| April 24, 2008 |
|
Arana and Kyowa Hakko to Co-develop Anti-Cancer Drug |
|
| April 14, 2008 |
|
Corporate presentation - April 08 |
|
| March 18, 2008 |
|
|
|
| March 18, 2008 |
|
ARANA THERAPEUTICS LIMITED (AAH) provides the opportunity to listen to an audio broadcast with Dr John Chiplin and Dr David Fuller, Managing Director / CEO and Chief Medical Officer in a presentation titled "AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer". |
|
| March 17, 2008 |
|
Arana Announces Start of Phase II Trial for Lead Compound |
|
| February 14, 2008 |
|
Arana AGM 2008 |
|
| February 4, 2008 |
|
|
|
| February 4, 2008 |
|
Arana achieves milestone in collaboration with CSL |
|
| February 1, 2008 |
|
Arana announces sale of animal health division |
|
| January 14, 2008 |
|
Arana Therapeutics Performance Share Plan |
|
| January 11, 2008 |
|
2008 shareholder notice of meeting for Arana
Therapeutics Limited |
|
| January 9, 2008 |
|
Arana announces final receipt of $17.7 million from sale
of Domantis Limited |
TOP |
| 2007 |
|
| December 28, 2007 |
|
Arana announces resignation of director |
|
| December 17, 2007 |
|
Relocation of registered office |
|
| December 11, 2007 |
|
Arana announces resignation of director |
|
| December 6, 2007 |
|
IBC Conference Presentation |
|
| December 5, 2007 |
|
|
|
| December 4, 2007 |
|
Arana Announces Phase II trials for Lead Compound ART621 |
|
| November 30, 2007 |
|
AAH - Arana Therapeutics Completes Project With CSL - Mr Rob Crombie, VP Business Development |
|
| November 29, 2007 |
|
Arana Therapeutics Completes Project With CSL |
|
| November 19, 2007 |
|
|
|
| November 19, 2007 |
|
Change of Director's Interest Notice |
|
| November 12, 2007 |
|
Arana investor presentation |
|
| November 9, 2007 |
|
Arana Therapeutics Reports Strong Financial |
|
| November 9, 2007 |
|
2007 Annual Results |
|
| November 8, 2007 |
|
Arana launches new business strategy |
|
| November 1, 2007 |
|
Peptech announces board changes |
|
| October 29, 2007 |
|
Peptech successfully completes Phase I trial for PN0621 |
|
| October 8, 2007 |
|
Notice of General Meeting |
|
| October 2, 2007 |
|
Peptech commercialisation agreement with AVEO |
|
| September 12, 2007 |
|
Peptech signs partner to distribute Suprelorin® in Europe |
|
| August 28, 2007 |
|
Peptech pays scheme consideration to evogenix shareholders |
|
| August 27, 2007 |
|
Peptech announces director retirements |
|
| August 17, 2007 |
|
Evogenix receives court order regarding merger with
Peptech |
|
| August 16, 2007 |
|
EvoGenix to commence second project with
GlaxoSmithKline |
|
| August 9, 2007 |
|
Shareholders Approve Peptech-Evogenix Merger |
|
| August 9, 2007 |
|
PTD Merger Announcement on ASX |
|
| July 13, 2007 |
|
|
|
| July 12, 2007 |
|
Peptech presentation to eG Capital Forum |
|
| July 11, 2007 |
|
Peptech presentation to eG Capital Forum |
|
| July 5, 2007 |
|
Change in Directors Interest Notice x 2 |
|
| June 28, 2007 |
|
EvoGenix Scheme Booklet |
|
| June 26, 2007 |
|
Peptech to conduct global search for new Chairman |
|
| June 22, 2007 |
|
Peptech wins Best Newcomer award 2007 at the Annual London Stock Exchange MediScience Awards |
|
| June 20, 2007 |
|
Peptech Half Year Report |
|
| June 18, 2007 |
|
Peptech renegotiates Biosceptre joint venture |
|
| June 13, 2007 |
|
Peptech establishes International Scientific Advisory Board |
|
| June 6, 2007 |
|
PTD - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec. Director and Dr Cliff Holloway, VP of Bus. Development |
|
| June 6, 2007 |
|
Peptech appoints Chief Medical Officer |
|
| May 22, 2007 |
|
PTD Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director |
|
| May 22, 2007 |
|
Peptech enters Phase I clinical trial of PN0621 |
|
| May 21, 2007 |
|
Peptech UK roadshow presentation |
|
| May 17, 2007 |
|
Record Profit for Half Year Boardroom Radio interview |
|
| May 17, 2007 |
|
Peptech announces record profit |
|
| May 17, 2007 |
|
Peptech 2007 Half Year Results |
|
| May 16, 2007 |
|
Chairman's letter to shareholders |
|
| May 8, 2007 |
|
Notice of initial substantial holder |
|
| May 7, 2007 |
|
Peptech and Evogenix merger Boardroom Radio interview |
|
| May 7, 2007 |
|
Peptech and Evogenix merger presentation |
|
| May 7, 2007 |
|
Peptech and Evogenix merge to form antibody powerhouse |
|
| May 3, 2007 |
|
Peptech’s Pipeline Boosted With A$6.6M Government Grant |
|
| May 1, 2007 |
|
Peptech presentation |
|
| April 30, 2007 |
|
Peptech to present at key international conferences |
|
| April 5, 2007 |
|
Peptech strengthens board with new appointment |
|
| March 26, 2007 |
|
GlaxoSmithKline has confirmed that EvoGenix has successfully met and exceeded the target set for improving the binding of a therapeutic protein to its target. |
|
| March 21, 2007 |
|
Peptech Animal Health Boardroom radio interview |
|
| March 19, 2007 |
|
Suprelorin® recommendation clears path for sales in Europe |
|
| March 16, 2007 |
|
Corporate presentation |
|
| March 16, 2007 |
|
Peptech antibody technology platform breakthrough |
|
| March 14, 2007 |
|
Peptech appoints global financial adviser |
|
| February 27, 2007 |
|
EvoGenix announced a technology collaboration with Circadian-backed Vegenics Ltd. In a non-exclusive deal, EvoGenix will apply its technology to help develop an anti-cancer antibody |
|
| February 23, 2007 |
|
EvoGenix has released its accounts for the half year to December, 2006 and a report on operations for the half year |
|
| February 8, 2007 |
|
Peptech AGM February 2007 |
|
| February 8, 2007 |
|
Peptech to explore private equity options |
|
| January 31, 2007 |
|
Peptech launches next generation Suprelorin12 |
|
| January 24, 2007 |
|
EvoGenix has been granted a patent by the US Patent Office covering development and work with Evibodies, small antibody-like proteins for use as therapeutics or diagnostics. |
|
| January 8, 2007 |
|
Peptech realises A$178m with Domantis sale completion |
|
|
